Cholesterol-lowering effects of DL-N-(alpha-methylbenzyl)-linoleamide and its optically active isomers in cholesterol-fed animals.
D000577:Amides / Q000627:therapeutic use*; D000818:Animals; D000924:Anticholesteremic Agents; D001161:Arteriosclerosis / Q000517:prevention & control*; D001555:Benzene Derivatives; D004036:Diet, Atherogenic; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008041:Linoleic Acids / Q000627:therapeutic use*; D008055:Lipids / Q000032:analysis; D008099:Liver / Q000032:analysis; D008297:Male; D008697:Methane; D011817:Rabbits; D051381:Rats; D013237:Stereoisomerism
D000577:Amides; D000924:Anticholesteremic Agents; D001555:Benzene Derivatives; D000960:Hypolipidemic Agents; D008041:Linoleic Acids; D008055:Lipids; D008697:Methane